Pathologic upstaging and survival outcomes for patients undergoing segmentectomy versus lobectomy in clinical stage T1cN0M0 non–small cell lung cancerCentral MessagePerspective

Objectives: To assess the impact of the extent of surgical resection on overall survival in patients with clinical T1cN0M0 (cT1cN0M0) non–small cell lung cancer (NSCLC), with and without pathologic nodal upstaging (pN1+). Methods: The National Cancer Database (NCDB) was queried to identify patients...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ryan C. Jacobs, MD, MS, Erik E. Rabin, MD, Charles D. Logan, MD, Sandeep N. Bharadwaj, MD, Hee Chul Yang, MD, Raheem D. Bell, MD, Emily J. Cerier, MD, Chitaru Kurihara, MD, Kalvin C. Lung, MD, Diego M. Avella Patino, MD, Samuel S. Kim, MD, Ankit Bharat, MBBS
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Series:	JTCVS Open
Subjects:	lung cancer lobectomy segmentectomy nodal staging survival
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666273625000403
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Pathologic upstaging and survival outcomes for patients undergoing segmentectomy versus lobectomy in clinical stage T1cN0M0 non–small cell lung cancerCentral MessagePerspective

Similar Items